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Abstract
Background: Toxoplasmosis endangers the unborn child if its infectious agent - toxoplasma gondii - is transmitted
transplacentally during pregnancy. Although this condition occurs in all parts of the world and represents a major
public health burden, no detailed knowledge on the global research architecture of congenital toxoplasmosis is
available thus far. Hence, it was the aim of this study to assess the related global research activity over the past
110 years.
Methods: We employed the NewQIS platform, which combines established scientometric and socioeconomic
analysis tools with novel visualizing techniques such as density equalizing mapping projections.
Results: In the Web of Science, 13,044 congenital toxoplasmosis-related items published between 1900 and 2012
were identified. These were issued by 26,483 authors originating from 125 countries. The US was the dominating
nation (38.7 % of total scientific output), followed by France (10.9 %) and Great Britain (9.2 %). The US also led the
ranking in regards to semi-qualitative parameters (total citations, country-specific h-indices and citation rates). When
research activity was related to economic figures, the ratio of total toxoplasmosis publications to the total GDP
listed Switzerland first with an average of 589.35 toxoplasmosis-related publications per GDP in 1000 Bio US-$, followed
by France (545.16), the UK (486.13) and Brazil (431.84) and the US (311.11). The relation of toxoplasmosis-specific
publications to the economic power indicator GDP per capita in 1000 US-$ revealed that the US was ranked first with
97.65 toxoplasmosis-related publications/GDP per capita in 1000 US-$, followed by Brazil (85.95). Subject area analysis
indicated a relative shortage of studies that addressed pharmacological or public health aspects of congenital
toxoplasmosis.
Conclusions: This study is the first in-depth approach to sketch a global picture of the congenital toxoplasmosis
research architecture. In contrast to other fields of biomedical research, not only high-income countries play a major
role regarding congenital toxoplasmosis research but also countries such as Brazil that have a high incidence of
congenital toxoplasmosis.
Background
Toxoplasmosis, caused by the obligate intracellular proto-
zoan Toxoplasma gondii (T. gondii), is a widespread zoo-
nosis of great importance worldwide [1]. The condition is
usually contracted by consumption of raw or undercooked
meat containing tissue cysts, or by ingesting food or water
contaminated with oocysts [1]. Infection during pregnancy
poses a major risk to the fetus due to transplacental trans-
mission [2]. Populations at risk for congenital toxoplasmo-
sis (CT) include immunocompetent women when become
newly infected in pregnancy or challenged with atypical
parasite strains as well as immunosuppressed mothers
with HIV/AIDS [3]. The risk of vertical transmission in-
creases during the course of the pregnancy whereas the
severity of fetal sequelae declines and depends on the
virulence of the T. gondii genotype [2]. Classic fetal mani-
festations include chorioretinitis, hydrocephalus and intra-
cranial calcifications. In up to 80 % of cases, the infection
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remains asymptomatic after birth, but infants will develop
learning and visual disabilities later in life [2, 4].
Many factors impact the epidemiology of T. gondii in-
fections such as environmental conditions (e.g. climate),
local density of felines, management of livestock and
habits of meat consumption. Average incidence rates of
4 T. gondii infections per 1000 pregnancies are reported
for European countries [5–8], while France is having the
highest incidence of congenital toxoplasmosis based on
2700 documented seroconversions in pregnant women
annually [9]. Other regions with a significant T. gondii
infection incidence include South America (e.g. inci-
dence rates of seven infections per 1000 pregnancies in
Argentina and up to 15 infections per 1000 pregnancies
in Colombia) and sub-saharan Africa [7, 10]. Numerous
genotypes of T. gondii have been identified so far. These
differ regarding their global distribution, prevalence and
virulence. Overall, three major subtypes (I, II, III) ac-
count for 95 % of isolates in North America and Europe.
5 % of subtypes are atypical genotypes of great genetic
diversity [11, 12] such as the BR 1 to 4 haplogroups de-
tected in Brazil [13]. Atypical toxoplasma create a more
virulent parasite population in South America so con-
genital toxoplasmosis presents more severely compared
to Europe. A large meta-analysis and a prospective co-
hort study showed a higher risk of ocular lesions for
Brazilian and Columbian than European children (47 %
versus 14 %). Further, these lesions were larger, more nu-
merous and more likely to affect the retina [14–16].
Research on congenital toxoplasmosis is a relatively
new field. T. gondii was initially described in 1908 [17]
and identified as the causative agent for neonatal en-
cephalomyelitis in the 1930s [18]. The mode of infection
by vertical transmission was published a decade later.
Important discoveries regarding the diagnosis of con-
genital toxoplasmosis, the life cycle and the virulence
mechanisms of T. gondii were made in the 1960s and
1970s based on the availability of novel immunological, cell
culture based, and molecular biological research methods
[19, 20]. In the 1990s and the new millennium, sophisti-
cated genetic approaches allowed the characterisation of
the numerous T. gondii genotypes worldwide [20, 21].
The omnipresent and highly prevalent parasite repre-
sents a threat to every non-infected pregnant women
around the globe [22]. The economic burden of toxo-
plasmosis is high. The costs - primarily attributed to
congenital toxoplasmosis - are estimated at nearly $8
billion yearly in the US alone [23]. Nevertheless, no stan-
dardised prevention measures such as vaccinations or an
optimal curative therapy have been developed so far
[24]. Also, public health interventions such pre- and
neonatal screening programs or surveillance networks
have been implemented in just a few nations globally [2].
Considering these unsolved challenges, further research
is necessary. Detailed knowledge on the global research
architecture of congenital toxoplasmosis is crucial for
planning scientific efforts, individual scholarship and
performance assessment in the field, but becomes chal-
lenging due to the vast number of related scientific pub-
lications available. Thus, scientometric methods can be
utilized for the systematic and reliable analysis of journal
articles. For this study, we employed the New Quality
and Quantity Indices in Science (NewQIS) platform [25],
which combines scientometric methods and advanced
visualizing procedures such as density equalizing map-
ping, to assess the global research on congenital toxoplas-
mosis over the past 110 years. Therefore, we focused on
quantitative and qualitative aspects of the research output,
geographical and chronological developments, existing re-
search networks and socio-economic benchmarking.
Methods
NewQIS protocol
The New Quality and Quantity Indices in Science (New-
QIS) platform encompasses a combination of established
economic and scientometric analysis tools together with
novel visualizing techniques such as density equalizing
mapping projections (DEMP). It was established in 2009
and described in detail previously [26, 27].
Data source
We used the Web of Science database (WoS core collec-
tion, Thomson Scientific) for data collection [28, 29].
This index database covers all CT-related scientific lit-
erature authored since 1900. It provided quantitative
data regarding the overall research output and enabled
us to assess citation parameters supplied by the Citation
Report.
Search strategy
Specific combinations of search terms containing con-
genital*, fetal*, prenatal* toxoplasm* and gondi* were
used. The asterisk was used as a wildcard for considering
variant forms of spelling [30]. We performed a “title” not
a “topic” search. This process minimized the inclusion of
off-topic and therefore unspecific publications in our
analysis. We restricted our investigation to the period
from 01.01.1900 to 31.12.2012 to avoid incomplete data
acquisition since the year 2013 was not completed at the
time the study was performed.
Data analysis and categorization
After retrieval of metadata in Plain Text Format, biblio-
graphic details were sorted in an interim database and
analysed according to specific and semi-qualitative cri-
teria. Quantitative criteria included countries of origin,
languages, document types, citations, cited references,
subject categories and year published. From extracted
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metadata, CT-specific modified H-indices and citation
rates, were calculated as semi-qualitative variables. The
H-index (HI) was developed by JORGE HIRSCH in 2005
and is a recognized parameter for the scientific quality
of publications [31]. To measure the chronologic evolu-
tion of the total global CT-associated research output,
we performed a regression analysis and calculated the
coefficient of determination (r2). r2 quantified the slope
of publication increase in correlation to two defined
time periods: (1) 1900 – 2012 (the total time period of
our investigation) and (2)1990 – 2012 (time period with
a visible pronounced increase in publication activity).
Density equalizing mapping
After raw data transfer to excel charts, the results were
illustrated in diagrams and visualized by DEMP as previ-
ously described in other NewQIS studies [32–35]. Based
on the algorithm of Gastner and Newman [36], the terri-
tories of the countries and their borders were resized in
proportion to the analysed variable, e.g. number of pub-
lications or citations, and a global sketch depicting spe-
cific aspects of the CT-related research activity was
created.
Economic analysis
In order to analyze a country’s scientific productivity in
the context of its economic resources and manpower, we
related its research output to recognized economic
benchmarks such as the gross domestic product (GDP)
per capita, and to the total economic power index GDP
per 1000 billion US-$. Economic statistics were obtained
from the World Economic Outlook Database of the
International Monetary Fund and the statistical yearbook
of the Federal Office of Statistics, Germany [37, 38]. The
data for the comparison of GDP per inhabitant were
taken from the World Development Indicators of The
World Bank [39, 40]. Further, we used the classification
issued by the World Bank to categorize the investigated
countries into high-income, upper-middle-income,
lower-middle-income and low-income countries (http://
data.worldbank.org/country/).
Analysis of collaborations
To investigate toxoplasmosis-related research collabora-
tions in a global context, all affiliations of the
toxoplasmosis-related publications were analysed as earl-
ier described for other diseases [41, 42]: In brief, if at
least two authors originating from different countries
contributed to one CT-related publication, this relation-
ship was defined as a collaboration. To visualize the
productivity of collaborations for single pairs of coun-
tries, a vector was generated. Its width and shade of grey
reflect the number of documented collaborative publica-
tions [41, 42].
Gender analysis
We investigated the distribution of male and female au-
thors and identified the countries where these re-
searchers were conducting their work. Only countries
with more than 300 authors, whose gender could be
identified in over 60 % of cases were included. In order
to identify the authors’ gender, we utilized online name
databases (http://www.vornamen-weltweit.de/ and http://
www.namepedia.org) and performed a manual search




We identified a total of 13,044 CT-related publications
issued between 1900 and 2012. 10,026 of these items
were articles. The publications were authored by 26,483
individuals originating from 125 countries and published
in 1600 journals. 94 % of the examined works were writ-
ten in English (12,257 publications), 2.1 % in French
(278 publications) and 1.6 % in German (211 publica-
tions). 93 of identified CT-related publications were
written in Spanish, 79 in Portuguese, 32 in Russian, 23
in Italian, 17 in Turkish, 15 in Polish and eight in Czech.
The first article indexed by WoS was published in
1913. Overall, we could document a very modest annual
publication output (maximum of 20 items per year) from
1940 to 1960. This publication activity increased steadily
after 1960 and was followed by a steep incline after
1990. In detail, we identified 91 publications for 1989. In
1993, this volume increased to 317 and the trend contin-
ued: In 2005, 536 items were issued, 806 in 2009 and
877 in 2012. Of the 13,044 articles that were published
in total, the majority of 11,226 (equal to 86.1 %) were
published between 1990 and 2012.
We quantified the slope of the increasing publication
output by regression analysis. For the period between
1940 and 2012, we found a r2 of 0.7314 compared to a
r2 of 0.9322 for the period between 1990 und 2012,
which documented a noticeable incline in research out-
put (Fig. 1b). Also, the number of participating authors
per publication increased over the time. While there was
an average of less than three authors involved per article
between 1966 and 1982, this number grew to more than
six in 2012 (data not shown).
Country-specific analysis
With 5045 publications, the United States (US) pub-
lished most items (38.7 % of the total volume) followed
by France (1425 articles, 10.9 %), the United Kingdom
(UK) (1204 articles, 9.2 %), Germany (1051 articles, 8 %)
and Brazil (973 articles, 7.5 %). Japan (553 articles),
Australia (397 articles), Switzerland (372 articles), Italy
(328 articles) and China (319 CT-specific publications)
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were among the ten top ranked countries. In a global
context, the US played the dominanting role regarding
CT-specific research output. Also, Western Europe,
Brazil and Japan occupied major territories on the world
map. The majority of Asian nations including Russian,
African and South American countries (with the excep-
tion of Brazil) were represented by only minimal areas
(Fig. 1a).
Regarding total citation number analysis, the US hold
position one with a total of 159,819 citations. It was
followed by the UK (35,383 citations), France (30,775 ci-
tations), Germany (22,015 citations), Australia (12,853
citations) and Brazil (11,674 citations) (Fig. 2a). Analys-
ing the modified H-index for countries, the highest HI
was attributed to the US (HI = 149) followed by the UK
(HI = 83), France (HI = 77) and Germany (HI = 62).
Fig. 1 Number of publications. a Density equalizing map of the global toxoplasmosis research activity assessed by publication output between
1900 and 2012. Colours and territorial sizes indicate numbers of toxoplasmosis publications per country. b Number of published items per year
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Fig. 2 Density equalizing maps of the global toxoplasmosis research quality. a Number of citations per country. b Toxoplasmosis-specific h-indices.
c Citation rate. Colours and territorial sizes indicate levels of toxoplasmosis-specific parameters
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Brazil was ranked 7 with an HI of 47, followed by
Australia (HI = 53) and Switzerland (HI = 49) (Fig. 2b).
In category “citation rate” (CR) a change in the ranking
was present with Australia reaching the highest level of
citations per CT-specific publication (32.4). It was
followed by the US (CR 31.7), Canada (CR 31.6), the UK
(CR 29.4), France (CR 21.6) and Germany (CR 20.9)
(Fig. 2c).
Economic analysis
When focussing at the gross domestic product as an in-
dicator for total economic strength and its relation to
the CT research output of single countries, all of the ten
most productive countries – except Australia and
Switzerland- belonged to the states with the highest total
GDP among the world (Table 1). The majority of these
nations represented high-income countries according to
the World Bank whereas the upper-middle-income
countries Brazil and China were the two exceptions.
The ratio of total publication number to total GDP
was used to determine the relative focus of a country on
toxoplasmosis research with regard to its overall eco-
nomic capability. Switzerland was listed first with an
average of 589.35 CT-related publications per GDP in
1000 Bio US-$. It was followed by France (545.16
publications/GDP in 1000 Bio US-$), the UK (486.13
publications/GDP in 1000 Bio US-$) and Brazil (431.84
publications /GDP in 1000 Bio US-$). The US was
ranked fifth (311.11 CT-related publications per GDP in
1000 Bio US-$) and Germany sixth (306.45 publications
per GDP in 1000 Bio US-$). The two Asian countries
Japan and China were ranked last (92.78 and 38.80 pub-
lications per GDP in 1000 Bio US-$, respectively) indi-
cating a relatively low interest and financial dedication
in toxoplasmosis-focussed research despite high absolute
numbers of publications i.e. in Japan. When the total
number of CT-related publications was related to the
relative economic power indicator GDP per capita in
1000 US-$, the US was again ranked first with 97.65
toxoplasmosis-related publications/GDP per capita in
1000 US-$, followed by Brazil (85.95 publications/
GDP per capita in 1000 US-$). Here, Switzerland leading
the absolute ranking due to its total GDP was found in
the last position with 4.71 publications/GDP per capita in
1000 US-$ (Tab. 1).
Subject area analysis
The categories “Parasitology” and “Veterinary Science”
represented the leading areas of CT research. 3406 publi-
cations were assigned to “Parasitology”, 1845 publications
to “Veterinary Science”. “Immunology” (1724 publica-
tions) and “Microbiology” (1702 publications) followed at
positions three and four. Publications in relatively new sci-
entific fields such as “Molecular Biology” or areas of basic
science were ranked lower at positions six and seven.
With regard to total citation numbers, the leading subject
areas were “Immunology” (66,767 citations), “Parasitology”
(61,111 citations) and “Microbiology” (38,878 citations)
(Fig. 3).
The percentage distribution of the ten most frequent
subject areas was analysed in regard to 5 year-periods
from 1963 onwards (Fig. 4a). The category “Tropical
Medicine” increased in absolute numbers from 1963 to
2012 while its relative proportion decreased between
1963 and 2002. A similar trend was visible for the cat-
egory “Microbiology”. Authors started to publish articles
in the new categories “Cell Biology” after 1973 and in
“Biochemistry and Molecular Biology” after 1978. The
category “Biochemistry & Molecular Biology” increased
both in absolute and relative numbers indicating an in-
creasing focus of this area of CT research over the years.
When analysing the relative and absolute levels of
assigned subject categories with regard to the most ac-
tive countries in toxoplasmosis research, “Parasitology”
Table 1 Socio-economic analysis of toxoplasmosis research of the ten most active countries. Sources for GDP and GDP per capita in
2012: [37–40]
Country Number of publications GDP in 1000 Bio US-$ Publications/GDP
in 1000 Bio US-$
GDP per capita in 1000 US-$ Publications/GDP
per capita
Type of country
Switzerland 372 0.6312 589.35 (1) 78.93 4.71 (10) HI
France 1425 2.6139 545.16 (2) 39.76 35.84 (4) HI
UK 1204 2.4767 486.13 (3) 38.65 31.15 (5) HI
Brazil 973 2.2531 431.84 (4) 11.32 85.95 (2) UMI
US 5054 16.2446 311.11 (5) 51.76 97.65 (1) HI
Germany 1051 3.4295 306.45 (6) 42.60 24.67 (6) HI
Australia 397 1.5417 257.50 (7) 67.44 5.88 (9) HI
Italy 328 2.0141 162.85 (8) 33.81 9.70 (8) HI
Japan 553 5.9603 92.78 (9) 46.55 11.88 (7) HI
China 319 8.221 38.80 (10) 6.09 52.35 (3) UMI
HI high-income, UMI upper-middle-income
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took a lead position in all countries except Italy (13 %).
In the US 24 %, in France 23 %, in the UK 30 %,
Germany 26 %, in Brazil 36 %, in Japan 30 % and in
China 53 % of all toxoplasmosis publications were pri-
marily assigned to this subject area. In four countries,
“Microbiology” was ranked second (France 19 %, UK
12.5 %, Germany 18 %, and Switzerland 15 %) whereas
“Veterinary Science” was ranked second in Brazil,
Australia and China indicating a difference in secondary
research focuses between these two country groups.
“Cell Biology” had a share between 1 and 8 % in each
country. “Pharmacology & Pharmacy” never exceeded
6 %. The category of “Tropical Medicine” ranked in the
positions seven to ten for all other countries (i.e. USA
1.5 %, France 2.1 %, Japan 1.6 %, Australia 2 %, Italy
2.1 % and Switzerland 1.3 %) with the exception of Brazil
(Fig. 4b).
International toxoplasmosis collaborations
Scientists from the US and France issued the first collab-
orative publication in 1973. The number of joined publi-
cations increased consistently until 2012. The assessment
of international collaborations demonstrated a leading
position of the US among the global scientific community
dedicated to CT-related research. Authors based in the
US participated in 1289 collaborative CT publications,
255 of those were collaborations with the UK. The second
highest number in bilateral collaborations was established
between the US and France (234 co-operations), followed
by the US and Brazil (171 co-operations), the US and
Germany (146 co-operations) and the US and Canada
(115 co-operations) (Fig. 5).
Gender analysis
We identified 26,483 authors who participated in CT-
related research; 48.8 % of those could be identified re-
garding their gender (n: 12,924). Generally, males were
over-represented with 7884 authors (61 %) compared to
5049 female authors (39 %). In almost all countries,the
number of male scientists was higher than their female
counterparts but we documented two exceptions: Brazil
and France. Here, female scientists clearly dominated.
We found 164 female authors working in France com-
pared to 141 male scientists; in Brazil, 343 female re-
searchers compared to 279 males.
Discussion
This study is the first in-depth analysis of the global con-
genital toxoplasmosis research activity regarding quanti-
tative and semi-qualitative aspects and in relation to
socio-economic variables. In total, 13,044 CT-related
publications were issued from 1900 to 2012. Until 1960,
the annual research output was low, followed by a steady
growth until 1990 and a steep incline afterwards. This
publication pattern is characteristic for most biomedical
research, studies on MRSA [34] or influenza [43] pro-
vide examples. The modest research activity in the first
60 years can be explained with the newness of the field.
The parasite had been known for only 50 years, its clin-
ical impact on human health was not fully discovered
yet and related research was not a priority for the
Fig. 3 Leading subject areas in the field of toxoplasmosis research
Brüggmann et al. Parasites & Vectors  (2015) 8:646 Page 7 of 13
Fig. 4 Subject area analyses. a Relative proportions of subject areas in 5-year intervals between 1963 and 2012. b Relative proportions of subject
areas in most active countries
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scientific community. Also, the overall publication activ-
ity was lower; researchers were not mainly assessed by
their publication merits. Beginning of the last century,
many articles were published in other languages than
English. These items were under-represented in our
search since the WoS indexes mainly English publica-
tions. In the 1960s, the growing reasearch output
correlated with milestones in CT research like the iden-
tification of the parasite’s life cycle, pathogenetic mecha-
nisms and relevant clinical implications of CT (e.g. the
discovery of the full scope of sequalae in humans). It is
remarkable that 86.1 % of all CT-related publications
were issued after 1990. This rapid incline might be re-
lated to the inclusion of additional publication types in
the WoS since 1991 [44]. Thus, publications other than
articles were picked up by our search. In the 1990s, the
widespread use of novel research techniques broadened
the opportunities to conduct and publish CT-related re-
search. Additionally, research networks such as the
“European Research Network on Toxoplasmosis” were
founded and surveillance programs had been in place
for almost 20 years (e.g. in France). We assume this
wealth of epidemiological data and international
collaborative efforts contributed significantly to this
strong CT-related publication output.
The US played the leading role in the global arena of
CT research: It published the highest number of items,
obtained most citations, had the highest h-index and
was home to most institutions conducting CT research.
These findings align with the study by Groneberg-Kloft
et al. [45], who analyzed the overall publication output
of the biomedical field from 1961 to 2007. Here, the US
issued 1,893,800 of 5,527,558 publications and was the
most productive country in regards to research on 21
organ systems [45]. This dominance might be attributed
to the fact that the US is allocating major resources to
research in general. In 2012, the nation dedicated 2.9 %
of its 16.244,6 billion US-Dollars GDP to scientific pur-
poses [37–40]. While the UK and Germany are also
known key players in the global arena of biomedical re-
search [45] and contributed 9.2 and 8 % of CT-specific
publication output respectively, our study provided the
remarkable result that France and Brazil were in simi-
larly leading positions. This finding can be explained by
the fact that the disease is of great national interest in
both countries: France has the highest incidence of CT
Fig. 5 Toxoplasmosis research collaborations between countries. Greyscale and bar thickness indicate intensity of collaborations. Ciphers in
brackets (total publication numbers / number of collaborative publications)
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in Europe, mainly due to the common consumption of
undercooked meat [2]. Tropical areas of South America
such as Brazil suffer from the highest burden of CT
worldwide due to the presence of highly virulent toxo-
plasma genotypes, high numbers of infected felines and
a climate facilitating oocyt survival [2, 46]. Brazil also
plays an important role in the global research activity on
other infectious and particularly parasitic diseases [47]:
In a study on yellow fever, Brazil ranked in position two
with 203 publications after the US (751 publications)
and was followed by France (149 publications) and the
UK (113 publications) [35]. A similar picture was also
present for leishmaniasis. Here, two studies assessed the
research output for the periods between 1957 and 2006
and 1945 and 2010 [48, 49]. Most publications came
from high-income countries such as the US, UK or
Germany, but Brazil was also found among the top lead-
ing countries [48]. For our study, we want to stress that
no other South American nation besides Brazil (e.g.
Columbia or Argentina) played an outstanding role re-
garding global CT research output. Brazil did not only
produce more but also higher cited publications - and
thus research of more advanced scientific quality and
recognition - than countries like Columbia, Argentina
and Chile (as shown in Fig. 2a, b and c). Also, the im-
pact of Eastern Mediterranean, and African regions was
marginal, although all have high incidences of CT (up to
3.4 CT cases per 1000 live births according to the
WHO) [50].
The relation of CT research activities to economic
data indicated that Switzerland, France, the UK and
Brazil invested the highest overall resources and gained
the highest research output when toxoplasmosis publica-
tion activity was related to absolute numbers of GDP.
However, when the toxoplasmosis research activities
were evaluated taking manpower into account and re-
lated to the per capita economic power (GDP/capita),
the picture changed and the US hold the first position
followed by Brazil; Switzerland ranked last. This analysis
of research output in relation to economic benchmarks
further illustrated the accentuated position of Brazil
among the key players of CT related research. We found
that Brazil - although an upper-middle-income country
among high-income countries - ranked second after the
US when CT-specific publications were related to the
relative economic power (measured in GDP per capita
in 1000 US-$). Here, 85.95 CT-related publications were
produced per GDP per capita in 1000 US-$ indicating
that this country invests a relatively high proportion of
its resources very effectively in toxoplasmosis research.
Overall, it can be stated that countries with high GDP
should have the capability to invest larger sums in
research and development, and thus can create more
attractive conditions for science. However, the GDP
should always also be considered in relation to the
population, which can change the picture. In this
respect, China is an impressive example in our study.
When focussing on subject categories in toxoplasmosis
research, we identified “Parasitology”, “Immunology”,
“Microbiology” and “Veterinary Science” as the leading
areas regarding publication and citation numbers. This
finding was not surprising. In this context, we want to
highlight that a rather small quantity of articles pub-
lished in the category “Immunology” received an ex-
tremely high number of citations pointing towards their
significant scientific quality. Regarding the chronological
evolution of categories, we documented that the relative
percentage of items published in “Tropical Medicine”
and “Microbiology” decreased from 1963 onwards. We
attribute this development to the fact that research on
T. gondii advanced over time shifting its focus from
identifying and locating the parasite to specific investiga-
tions regarding its life cycle, transmission patterns and
clinical implications. This shift in scientific interest cor-
related with an increased percentage of published items
found in other categories, e.g. in “Immunology” since
1968. The rising interest in this particular area might be
explained by the onset of serologic testing – still the cor-
ner stone for diagnosis of CT today [20, 51–53] - in the
1960s based on the description of antibody structures by
Cohen and Porter [54]. During the 1970s, we docu-
mented a visible growth of publication activity in “Cell
Biology”. This also corresponds with the historical mile-
stones at this time: Researchers decoded the invasion
processes, life cycle of the parasite and transmission pat-
terns with the help of cell biological methods. Also, the
molecular biological method of polymerase chain reac-
tion (PCR) was developed in 1987 [55]. Since PCR plays
a crucial role in fetal diagnosis of CT [1, 56, 57] and al-
lows to characterize different T. gondii genotpypes,
which became increasingly relevant in the 90s [12, 20],
this technique might have contributed significantly to
growing volume of publications in the area of “Biochem-
istry and Molecular Biology”. In our analysis, it became
evident that no publications were attributed to the cat-
egory of “Public Health”. Since CT has an tremendous
global impact on the health of mothers and their off-
spring, our finding illustrates the apparent need to in-
crease the worldwide implementation of Public Health
measures and their assessment [15]. Furthermore, the
relatively small proportion of toxoplasmosis research in
the field of pharmacology indicates that this area should
receive more attention in future.
France and Brazil were identified as nations with more
female than male authors participating in CT-associated
research. A similar gender distribution was found for
Rotavirus-related research [58]. The authors explained
their results with the Brazilian culture of encouraging
Brüggmann et al. Parasites & Vectors  (2015) 8:646 Page 10 of 13
female scientists to particularly participate in economy,
science and technology as shown by three large bench-
marking studies [58, 59]. However, we could identify
only 48.8 % of author names regarding their gender.
Common difficulties were encountered when names
were documented as initials, were gender neutral and
not listed in accessable name databases. Hence, this part
of our study has to be viewed critically.
On international level, we found a growing number of
collaborations since 1973, which was congruent with an
increasing number of authors per paper. This develop-
ment might be related to the overall trend to conduct
research as collaborative efforts but also be based on
emerging, well funded research networks such as the
international “Systematic Review On Congenital Toxo-
plasmosis (SYROCOT) study group” or the “European
Research Network on Toxoplasmosis” [14]. We identi-
fied the US as the nation involved in the highest number
of international collaborations – most of these were
established between the US and the UK, France and
Germany. This picture corresponds to other studies [60]
and can be explained with the excellent scientific infra-
structure and the majority of institutions working on
CT-related research based in the US. Also, Brazil issued
262 of its 973 published paper in conjuction with US
American scientists. This finding is remarkable and can
be explained by the dedicated support of the Brazilian
government and the unique opportunities researchers
gain in regards to the specific T. gondii populations en-
demic in South America [46].
The infection of pregnant women and unborn children
still challenge healthcare providers from a global per-
spective. Hence, we want to point out the necessity to
include low-resource countries with high CT incidence
rates (e.g. located in Central/South America or the East-
ern Mediterranean [50]) in strong scientific collabora-
tions. Here, epidemiological data, ideas and gained
knowledge can be exchanged to the benefit of all partici-
pants. In this context, we want to underline the ethical
responsibility to involve African countries in collabora-
tive efforts. Currently, these nations play no visible role
within the global CT research community but should par-
ticipate since they have not only high prevalences of CT
but also a large demographic of toxoplama-susceptible
women with HIV and no adequate therapy (e.g. Ethopia)
[61]. Furthermore, collaborations should focus on includ-
ing countries with access to vast epidemiological data
from prenatal and neonatal CT screening or surveillance
programs such as France, Austria, Italy, Denmark, Poland
[7]. Since global travel increases, atypical parasites from
South America will also become more relevant for Europe.
Here, close-knit networks and shared public health efforts
allowing the exchange of epidemiological data, ideas and
resources are essential for effective prevention.
Regarding the strengths of our study, we employed the
WoS for raw data acquisition due to its unique feature
to generate detailed citation for single index entries.
These enabled us to calculate semi-qualitative variables
such as country-specific citation rates or h-Indices,
which added valuable aspects to our assessment. Also,
CT is a newly researched field. Hence, using the WoS
provided us with the particular opportunity to investi-
gate the complete chronological development of the re-
lated research output. Nevertheless, one bias of our
study is linked to the WoS’s focus on English publica-
tions. Hence, non-English items – particularly when
published before 1940 – might be under-represented in
our analysis. Also, we hypothesize that articles written in
Spanish and Portuguese describing early research con-
ducted in countries with high T. gondii prevalence such
as Colombia, Argentina or Brazil might not have been
identified by our search; the Scielo bibliographic data-
base would be an appropriate source to investigate these.
On the other hand, this language bias might be limited
since Thompson Reuters stated that 90 % of cited and
75 % of published items related to a specific topic are
indexed by the WoS. Also, non-English speaking coun-
tries usually publish their high quality research in Eng-
lish journals [62]. Another bias might be related to the
citation parameters serving as proxies for scientific qual-
ity. Although this relationship between citation numbers
and scientific quality is well established, it might be
skewed due to the common habit of self-citing and the
Matthew effect. Here, publications issued by well known
scientists are cited more than junior scientists leading to
an exponential growth of citation counts [63].
Conclusions
In summary, this study is the first in depth analysis of
the worldwide toxoplasmosis research architecture. Using
density-equalizing mapping techniques, a global landscape
was sketched representing quantitative and qualitative
toxoplasmosis research aspects. The US has a leading role
in the field followed by other high-income countries.
Brazil occupied an emphasized position in the scientific
community, which reflects the country’s dedication to CT-
related research to fight a disease that puts a major burden
on the health of its inhabitants. Also, our study highlights
the apparent need to conduct research in the field of Pub-
lic Health: Interventions should be tailored to the contin-
ent since the disease presents differently in South America
than Europe. Also, we have to update our educational ef-
forts to inform about potential exposure to highly viruent
T. gondii genotypes due to traveling or consumption of
imported foods.
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